SORABUZZ TABLET 120'S

SORABUZZ TABLET 120'S may harm an unborn baby and should not be used during pregnancy. It is also not recommended while breastfeeding, as it may pass into breast milk and harm the nursing infant.

Fatigue, weakness, diarrhea, nausea, vomiting, lack of appetite, hand-foot skin reaction (palmar-plantar erythrodysesthesia), rash, hair thinning, elevated blood pressure, and abnormal liver enzyme levels are common adverse effects of SORABUZZ TABLET 120'S.

Alopecia, or hair thinning or loss, is a possible adverse effect of SORABUZZ TABLET 120'S therapy, however it is less frequent than with certain other chemotherapy medications. While using SORABUZZ TABLET 120'S, not every patient will experience hair loss, and each patient's level of hair thinning will differ.

The decision to use SORABUZZ TABLET 120'S in individuals with diabetes should be made on a case-by-case basis. SORABUZZ TABLET 120'S may affect blood glucose levels, and individuals with diabetes may experience changes in glycemic control while taking the medication.

The length of SORABUZZ TABLET 120'S treatment varies based on patient-specific factors such tolerability, treatment response, and cancer kind and stage. While some individuals would only need a SORABUZZ TABLET 120'S for a few months, others might need ongoing care. The length of treatment that is right for you will be decided by your healthcare practitioner based on your particular circumstance.

It is not recommended to eat foods high in fat content while on treatment with a SORABUZZ TABLET 120'S. Tell your healthcare provider before taking Sorafenib if you are taking any prescription medicines, over the counter drugs, vitamins or herbal supplements.

There is no known interaction of SORABUZZ TABLET 120'S with other drugs.

Follow all instructions and dosing recommendations provided by your healthcare provider. Do not take more or less of the medication than prescribed. Report any new or worsening symptoms to your healthcare provider immediately, especially if they relate to your lungs, eyes, skin, liver, kidneys, heart, or bleeding. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. SORABUZZ TABLET 120'S should not be stopped without first talking to your doctor. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping SORABUZZ TABLET 120'S. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately.

SORAFENIB is molecule/combination used for making SORABUZZ TABLET 120'S.

SORABUZZ TABLET 120'S is prescribed for ailments/diseases/conditions related to Oncology.